How to Treat Vaginal Atrophy Effectively

Burning when you pass urine, dryness during the day, discomfort with sex, or recurrent ‘UTI-like’ symptoms can all stem from the same issue: changes to the vaginal and urinary tissues caused by lower oestrogen. Knowing how to treat vaginal atrophy can be genuinely life-changing, particularly when symptoms have begun to affect sleep, relationships, confidence or everyday comfort.

Vaginal atrophy is common in perimenopause and after menopause, but it is not something you simply have to put up with. Effective treatments are available, and the right approach depends on your symptoms, medical history, preferences and whether you also need treatment for wider menopause symptoms.

What is vaginal atrophy?

Vaginal atrophy is often now discussed as part of genitourinary syndrome of menopause, or GSM. As oestrogen levels fall, the lining of the vagina, vulva, bladder and urethra can become thinner, drier and less elastic. Natural lubrication reduces, and the vaginal environment becomes less acidic. These changes may develop gradually and can continue or worsen without treatment.

Symptoms vary. Some women notice vaginal dryness, itching, soreness or a feeling of tightness. Others find penetrative sex uncomfortable or painful, even when they feel emotionally ready for intimacy. Urinary urgency, stinging, frequency and repeated urine infections can also be part of the picture.

Although menopause is the most common cause, similar symptoms can occur after cancer treatments, removal of the ovaries, while breastfeeding, or with medicines that lower oestrogen. Persistent symptoms should be assessed rather than assumed to be hormonal, as skin conditions, infections and other causes may need different treatment.

How to treat vaginal atrophy: start with local treatment

For many women, vaginal oestrogen is the most effective first-line treatment for vaginal atrophy. It replaces a very small amount of oestrogen directly in the affected tissues and is available as a cream, pessary, vaginal tablet, gel or flexible ring. The choice is practical as much as clinical: some people prefer the convenience of a ring, while others find a cream helpful when external vulval symptoms are prominent.

Treatment usually begins with a short daily course to restore the tissues, followed by a lower maintenance schedule. The exact regimen depends on the product prescribed. Improvement may start within a few weeks, but fuller benefit can take several months. Unlike symptoms such as hot flushes, vaginal atrophy generally does not resolve on its own over time, so ongoing treatment is often needed to maintain comfort.

Low-dose vaginal oestrogen has very little absorption into the bloodstream. For most women, it can be used long term and alongside systemic HRT. It is also commonly suitable for women who cannot take systemic HRT, though individual circumstances matter. If you have had breast cancer, particularly hormone-sensitive breast cancer, treatment should be considered with your oncology team or a clinician experienced in menopause and cancer care. This is an area where personalised discussion is essential, not a reason to suffer in silence.

If you are already using HRT

Systemic HRT, such as oestrogen gel, patches or tablets, can help many menopause symptoms, including hot flushes, sleep disruption and mood changes. However, it may not fully treat vaginal or urinary symptoms. It is common, appropriate and often beneficial to use local vaginal oestrogen in addition to systemic HRT when needed.

If dryness or painful sex persists despite otherwise well-managed menopause symptoms, it is worth reviewing the local treatment rather than assuming your HRT is failing. Dose, formulation, application technique and other contributors to discomfort all deserve consideration.

Moisturisers and lubricants can make a real difference

Non-hormonal vaginal moisturisers and lubricants are useful whether or not you use vaginal oestrogen. They do different jobs. A moisturiser is used regularly, usually several times a week, to support day-to-day hydration. A lubricant is used at the time of sexual activity to reduce friction and discomfort.

Look for products designed for vaginal use and avoid perfumed washes, fragranced wipes and products that sting or irritate. Water- or silicone-based lubricants are often well tolerated, although the best choice can depend on personal preference and whether condoms or sex toys are used. Oil-based products can damage latex condoms.

Moisturisers and lubricants may be enough for mild symptoms or when hormones are not suitable. For moderate or severe vaginal atrophy, they often work best alongside targeted medical treatment rather than as a replacement for it.

Address pain with care, not pressure

When sex has become painful, it can be tempting to avoid intimacy altogether. That response is understandable, but discomfort can lead to anxiety, involuntary tightening of the pelvic floor and a cycle in which penetration becomes increasingly difficult.

There is no requirement to have penetrative sex while treatment takes effect. Taking pressure off, allowing time for arousal, using lubricant generously and exploring forms of intimacy that feel comfortable can help. Some women benefit from pelvic health physiotherapy, particularly where pelvic floor tension, prolapse symptoms or pain persists after vaginal dryness has improved.

If symptoms include bleeding after sex, a new discharge, sores, marked itching or persistent pain, seek a clinical assessment promptly. These symptoms are often treatable, but they should not be self-diagnosed as vaginal atrophy.

Other prescription options may be considered

When local oestrogen is unsuitable, ineffective or not preferred, a specialist may discuss alternatives. Prasterone, used vaginally, may improve dryness and painful sex for some postmenopausal women. Ospemifene is an oral medicine that acts on oestrogen receptors and may be considered in selected circumstances.

These options are not interchangeable, and access, suitability, side effects and medical history all matter. A thorough consultation can establish whether symptoms are purely local, part of broader menopause hormone changes, or complicated by dermatological, urinary or pelvic floor concerns.

Energy-based treatments, sometimes marketed as vaginal laser or radiofrequency rejuvenation, are another area where careful advice matters. Evidence and long-term safety data are currently more limited than for established treatments such as vaginal oestrogen. They should not be viewed as a routine substitute for guideline-led medical care.

When should you seek specialist support?

You deserve a review if symptoms are affecting your quality of life, recurring despite treatment, or leaving you unsure what is safe to use. A specialist assessment allows time to discuss your medical history, current hormones, sexual wellbeing, urinary symptoms and treatment goals. Examination may be recommended, but it should always be explained, undertaken sensitively and carried out with your consent.

For women with early menopause, primary ovarian insufficiency, previous gynaecological surgery, cancer treatment, complex HRT needs or a history of recurrent urinary symptoms, a personalised plan is especially valuable. Treatment is not one-size-fits-all, and feeling heard is part of good care.

Vaginal atrophy is a physical consequence of changing hormones, not a failure of desire, femininity or resilience. With the right treatment, many women regain comfort, confidence and an enjoyable sex life. To discuss your symptoms and treatment choices with an experienced clinician, please visit our consultations page.